SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001773427-23-000012
Filing Date
2023-03-10
Accepted
2023-03-10 17:23:43
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K swtx-20230310.htm   iXBRL 8-K 34418
  Complete submission text file 0001773427-23-000012.txt   169086

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20230310.xsd EX-101.SCH 1905
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20230310_lab.xml EX-101.LAB 23804
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20230310_pre.xml EX-101.PRE 12510
6 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20230310_htm.xml XML 11110
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 23724914
SIC: 2836 Biological Products, (No Diagnostic Substances)